Welcome to our dedicated page for STANDEX INTERNATIONAL CORP/DE/ SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on STANDEX INTERNATIONAL CORP/DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into STANDEX INTERNATIONAL CORP/DE/'s regulatory disclosures and financial reporting.
STANDEX INTERNATIONAL CORP (SXI) reported that director Charles H. Cannon Jr. acquired 286 Phantom Stock Units as a grant classified as a “grant, award, or other acquisition.” These units are tied to 286 shares of Common Stock and are scheduled to vest three years after the purchase date under the company’s Management Stock Purchase Plan component of the 2018 Omnibus Incentive Plan. Following this award, Cannon’s directly held Phantom Stock Units position reported in this filing is 286 units.
STANDEX INTERNATIONAL CORP (SXI) reported that director Barbara Joanne Edwards acquired 143 Phantom Stock Units on August 23, 2026. These units were granted under the Management Stock Purchase Plan component of the 2018 Omnibus Incentive Plan and are scheduled to vest three years after the purchase, in the form of Common Stock.
STANDEX INTERNATIONAL CORP (SXI) reported that director Robin J. Davenport acquired additional common stock on August 21, 2026. The filing shows an award-type acquisition of 2.681 shares at $308.075 per share, increasing Davenport’s direct holdings to 4,710.946 SXI shares. A footnote states the shares were obtained through the company’s Dividend Reinvestment Plan, indicating automatic reinvestment of dividends rather than an open-market purchase.
STANDEX INTERNATIONAL CORP (SXI) has a notice of proposed sale of securities filed for the account of officer Alan J. Glass under Rule 144. The notice covers up to 1,391 shares of common stock, to be sold through Fidelity Brokerage Services LLC on or about 08/24/2026.
The shares relate to restricted stock vesting on 08/23/2026 as compensation from the issuer. The filing lists an aggregate market value of $421,839.23 for the shares and notes 12,119,465 shares of common stock outstanding, which is a baseline figure, not the amount being offered.
STANDEX INTERNATIONAL CORP (SXI) is named as the issuer in a notice of proposed sale of securities filed under Rule 144 for the account of Ademir Sarcevic. The planned transaction involves SXI common stock held at Fidelity Brokerage Services LLC. The securities to be sold are 2,300 shares of common stock, which are noted as having been acquired from the issuer through restricted stock vesting on 08/23/2026 as compensation. The filing indicates an intended sale through the NYSE around 08/24/2026, and it shows no other sales of these securities during the past three months.
Standex International Corporation reported fiscal 2026 net sales of $891.6 million, up 12.8% from 2025, with gross margin improving to 41.7%. Income from operations rose to $193.6 million, more than double the prior year, aided by a $57.1 million gain on the sale of Federal Industries.
Growth was driven by the Electronics and Aerospace & Defense segments, acquisitions across grid, defense and life sciences markets, and higher sales into fast growth markets of $263.8 million. Backlog realizable within one year increased 29.7% to $318.5 million, supporting 2027 sales visibility, while higher debt for acquisitions lifted interest expense to $30.7 million.
Slaughter Richard Colby reported acquisition or exercise transactions in this Form 4 filing.
Standex International Corp. (SXI) reported that officer Richard Colby Slaughter, CLO, VP and Secretary, received a grant of 2,285 Restricted Stock Units on August 10, 2026. These RSUs are tied to common stock and vest in three equal installments on August 10, 2027, August 10, 2028, and August 10, 2029. Following this award, he holds 2,285 RSUs directly.
Standex International Corp. (SXI) reported an initial statement of beneficial ownership for Richard Colby Slaughter, who serves as CLO, Vice President and Secretary. This Form 3 filing lists him as a reporting person but does not report any equity transactions or holdings in issuer securities.
Standex International director Thomas E. Chorman sold 50 shares of Common Stock on August 3, 2026 at $305.56 per share in an open-market or private transaction. Following the sale, he directly holds 12,366 shares. The trade was executed under a Rule 10b5-1 trading plan dated November 6, 2025.
Thomas Chorman filed to sell 50 shares of SXI common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $15,278.00 and an anticipated sale date of 08/03/2026. These shares were acquired via restricted stock vesting from the issuer as compensation on 10/26/2024.
Over the prior three months, Chorman sold 50 shares of common stock on 06/01/2026 for $13,641.00 and another 50 shares on 07/01/2026 for $17,775.50.